Company: TVRD
Filing Date: 2025-10-20
Form Type: S-1/A
Source: 0001104659-25-100896
Chunk: 264

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-10-20
Form: S-1/A
Chunk 264
---
 issuable under the 2025 ESPP may be shares of authorized but unissued or reacquired our common stock, including shares purchased by the Company on the open market. Shares subject to purchase rights granted under the 2025 ESPP that terminate without having been exercised in full will not reduce the number of shares available for issuance under the 2025 ESPP.

<div align='center'>161</div>

TABLE OF CONTENTS

Administration . The Company’s board of directors, or a duly authorized committee thereof, will administer the 2025 ESPP.

Eligibility . The Company’s employees and the employees of any of its designated affiliates, will be eligible to participate in the 2025 ESPP, provided they may have to satisfy one or more of the following service requirements before participating in the 2025 ESPP, as determined by the administrator: (1) customary employment with the Company or one of its affiliates for more than 20 hours per week and more than five months per calendar year or (2) continuous employment with the Company or one of its affiliates for a minimum period of time, not to exceed two years, prior to the first date of an offering. In addition, the Company’s board of directors may also exclude from participation in the 2025 ESPP or any offering, employees who are “highly compensated employees” (within the meaning of Section 423(b)(4)(D) of the Code) or a subset of such highly compensated employees. An employee may not be granted rights to purchase stock under the 423 Component of the 2025 ESPP (a) if such employee immediately after the grant would own stock (including stock issuable upon exercise of all such employee’s purchase rights) possessing 5% or more of the total combined voting power or value of all classes of our common stock or (b) to the extent that such rights would accrue at a rate that exceeds $25,000 worth of our common stock for each calendar year that the rights remain outstanding. The Company’s board of directors may approve different eligibility rules for the Non-423 Component.

Offerings . The 423 Component of the 2025 ESPP is intended to qualify as an employee stock purchase plan under Section 423 of the Code. The administrator may specify offerings under the 423 Component with a duration of not more than 27 months and may specify one or more shorter purchase periods within each offering. For the Non-423 Component, the administrator may specify offerings, and purchase periods within each offering,